Clinical Value of Combined Multi-Indicator Tests in Diagnosis of Benign Ovarian

Lunyun Yang,1 Lin Du,2 Bailong Hou,1 Xiaoqin Niu,1 Wei Wang,1 Weifeng Shen1 1Department of Laboratory Medicine, The Affiliated Hospital of Jiaxing University, Jiaxing, 314000, People’s Republic of China; 2The Third Xiangya Hospital of Central South University, Changsha, 430074, People’s Republic of...

Full description

Bibliographic Details
Main Authors: Yang L, Du L, Hou B, Niu X, Wang W, Shen W
Format: Article
Language:English
Published: Dove Medical Press 2023-05-01
Series:International Journal of General Medicine
Subjects:
Online Access:https://www.dovepress.com/clinical-value-of-combined-multi-indicator-tests-in-diagnosis-of-benig-peer-reviewed-fulltext-article-IJGM
_version_ 1797816403633373184
author Yang L
Du L
Hou B
Niu X
Wang W
Shen W
author_facet Yang L
Du L
Hou B
Niu X
Wang W
Shen W
author_sort Yang L
collection DOAJ
description Lunyun Yang,1 Lin Du,2 Bailong Hou,1 Xiaoqin Niu,1 Wei Wang,1 Weifeng Shen1 1Department of Laboratory Medicine, The Affiliated Hospital of Jiaxing University, Jiaxing, 314000, People’s Republic of China; 2The Third Xiangya Hospital of Central South University, Changsha, 430074, People’s Republic of ChinaCorrespondence: Weifeng Shen, Department of Laboratory Medicine, The Affiliated Hospital of Jiaxing University, No. 1882, Zhonghuan South Road, Nanhu District, Jiaxing, Zhejiang, 314000, People’s Republic of China, Tel +86-18868345828, Email swf15960220793@126.comBackground: To investigate the existence and degree of correlation between benign ovarian tumors and physiological indicators such as reproductive hormones and tumor markers.Methods: A total of 150 patients with benign ovarian tumors admitted to Jiaxing First Hospital between January 1, 2019, and May 30, 2021, were enrolled as research subjects, while 104 healthy women were enrolled in the control group. Comparative analysis of the correlation between the reproductive hormones LH, FSH, T, E2, and the tumor indicators AMH, AFP, CEA, CA125, and CA199 between the groups was performed.Results: There was no statistical difference in LH, FSH, T, AMH, and CEA expression levels between the experimental and control groups (p≥ 0.05); E2, CA125, and CA199 levels were higher significantly in the experimental group than in the control group (P< 0.001); AFP levels were significantly lower in the experimental group than in the control group (P< 0.05). CA125 (0.762) had the highest AUC when diagnosing the value of each index of E2, CA125, and CA199 for benign ovarian tumors. CA125 had the highest sensitivity (56.7%), followed by E2 (50.0%); CA199 had the highest specificity (84.5%), followed by CA125 (83.7%). The combined diagnosis of benign ovarian tumors was performed using different combinations of the indicators. When the two indicators were combined for diagnosis, the combination of E2 + CA199 had the highest sensitivity (82.6%), whereas the combination of CA125 + CA199 had the largest AUC (0.783) and the highest specificity (86.4%). The combined diagnosis of E2+CA125+CA199 had a higher AUC than the combined diagnosis of the two indicators (0.805), with a sensitivity of 77.2%, and a specificity of 70.9%.Conclusion: The most relevant factors for benign ovarian tumors are E2, CA125, and CA199 and the combination of these three indicators has the highest AUC for disease prediction while increasing the detection rate of benign ovarian tumors.Keywords: benign ovarian tumors, tumor markers, reproductive hormones
first_indexed 2024-03-13T08:37:07Z
format Article
id doaj.art-7bcc1d5f80f34a2ba54f4fff955d5df7
institution Directory Open Access Journal
issn 1178-7074
language English
last_indexed 2024-03-13T08:37:07Z
publishDate 2023-05-01
publisher Dove Medical Press
record_format Article
series International Journal of General Medicine
spelling doaj.art-7bcc1d5f80f34a2ba54f4fff955d5df72023-05-30T19:13:35ZengDove Medical PressInternational Journal of General Medicine1178-70742023-05-01Volume 162047205384025Clinical Value of Combined Multi-Indicator Tests in Diagnosis of Benign OvarianYang LDu LHou BNiu XWang WShen WLunyun Yang,1 Lin Du,2 Bailong Hou,1 Xiaoqin Niu,1 Wei Wang,1 Weifeng Shen1 1Department of Laboratory Medicine, The Affiliated Hospital of Jiaxing University, Jiaxing, 314000, People’s Republic of China; 2The Third Xiangya Hospital of Central South University, Changsha, 430074, People’s Republic of ChinaCorrespondence: Weifeng Shen, Department of Laboratory Medicine, The Affiliated Hospital of Jiaxing University, No. 1882, Zhonghuan South Road, Nanhu District, Jiaxing, Zhejiang, 314000, People’s Republic of China, Tel +86-18868345828, Email swf15960220793@126.comBackground: To investigate the existence and degree of correlation between benign ovarian tumors and physiological indicators such as reproductive hormones and tumor markers.Methods: A total of 150 patients with benign ovarian tumors admitted to Jiaxing First Hospital between January 1, 2019, and May 30, 2021, were enrolled as research subjects, while 104 healthy women were enrolled in the control group. Comparative analysis of the correlation between the reproductive hormones LH, FSH, T, E2, and the tumor indicators AMH, AFP, CEA, CA125, and CA199 between the groups was performed.Results: There was no statistical difference in LH, FSH, T, AMH, and CEA expression levels between the experimental and control groups (p≥ 0.05); E2, CA125, and CA199 levels were higher significantly in the experimental group than in the control group (P< 0.001); AFP levels were significantly lower in the experimental group than in the control group (P< 0.05). CA125 (0.762) had the highest AUC when diagnosing the value of each index of E2, CA125, and CA199 for benign ovarian tumors. CA125 had the highest sensitivity (56.7%), followed by E2 (50.0%); CA199 had the highest specificity (84.5%), followed by CA125 (83.7%). The combined diagnosis of benign ovarian tumors was performed using different combinations of the indicators. When the two indicators were combined for diagnosis, the combination of E2 + CA199 had the highest sensitivity (82.6%), whereas the combination of CA125 + CA199 had the largest AUC (0.783) and the highest specificity (86.4%). The combined diagnosis of E2+CA125+CA199 had a higher AUC than the combined diagnosis of the two indicators (0.805), with a sensitivity of 77.2%, and a specificity of 70.9%.Conclusion: The most relevant factors for benign ovarian tumors are E2, CA125, and CA199 and the combination of these three indicators has the highest AUC for disease prediction while increasing the detection rate of benign ovarian tumors.Keywords: benign ovarian tumors, tumor markers, reproductive hormoneshttps://www.dovepress.com/clinical-value-of-combined-multi-indicator-tests-in-diagnosis-of-benig-peer-reviewed-fulltext-article-IJGMbenign ovarian tumorstumor markersreproductive hormones
spellingShingle Yang L
Du L
Hou B
Niu X
Wang W
Shen W
Clinical Value of Combined Multi-Indicator Tests in Diagnosis of Benign Ovarian
International Journal of General Medicine
benign ovarian tumors
tumor markers
reproductive hormones
title Clinical Value of Combined Multi-Indicator Tests in Diagnosis of Benign Ovarian
title_full Clinical Value of Combined Multi-Indicator Tests in Diagnosis of Benign Ovarian
title_fullStr Clinical Value of Combined Multi-Indicator Tests in Diagnosis of Benign Ovarian
title_full_unstemmed Clinical Value of Combined Multi-Indicator Tests in Diagnosis of Benign Ovarian
title_short Clinical Value of Combined Multi-Indicator Tests in Diagnosis of Benign Ovarian
title_sort clinical value of combined multi indicator tests in diagnosis of benign ovarian
topic benign ovarian tumors
tumor markers
reproductive hormones
url https://www.dovepress.com/clinical-value-of-combined-multi-indicator-tests-in-diagnosis-of-benig-peer-reviewed-fulltext-article-IJGM
work_keys_str_mv AT yangl clinicalvalueofcombinedmultiindicatortestsindiagnosisofbenignovarian
AT dul clinicalvalueofcombinedmultiindicatortestsindiagnosisofbenignovarian
AT houb clinicalvalueofcombinedmultiindicatortestsindiagnosisofbenignovarian
AT niux clinicalvalueofcombinedmultiindicatortestsindiagnosisofbenignovarian
AT wangw clinicalvalueofcombinedmultiindicatortestsindiagnosisofbenignovarian
AT shenw clinicalvalueofcombinedmultiindicatortestsindiagnosisofbenignovarian